CHMP recommends marketing authorisation of pioglitazone/glimepiride

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2006

Schlagwörter:	Diabetes Mellitus Marketing Type Diabetes Mellitus Metformin Type Diabetes

Anmerkung:	© Adis International Ltd 2006

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1562(2006), 1 vom: Nov., Seite 22-22
Übergeordnetes Werk:	volume:1562 ; year:2006 ; number:1 ; month:11 ; pages:22-22

Links:	Volltext

DOI / URN:	10.2165/00128413-200615620-00062

Katalog-ID:	SPR035267208

Internformat


LEADER	01000caa a22002652 4500
001	SPR035267208
003	DE-627
005	20230519084836.0
007	cr uuu---uuuuu
008	201007s2006 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200615620-00062 \|2 doi
035			\|a (DE-627)SPR035267208
035			\|a (SPR)00128413-200615620-00062-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a CHMP recommends marketing authorisation of pioglitazone/glimepiride
264		1	\|c 2006
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2006
650		4	\|a Diabetes Mellitus \|7 (dpeaa)DE-He213
650		4	\|a Marketing \|7 (dpeaa)DE-He213
650		4	\|a Type Diabetes Mellitus \|7 (dpeaa)DE-He213
650		4	\|a Metformin \|7 (dpeaa)DE-He213
650		4	\|a Type Diabetes \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1562(2006), 1 vom: Nov., Seite 22-22 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1562 \|g year:2006 \|g number:1 \|g month:11 \|g pages:22-22
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200615620-00062 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1562 \|j 2006 \|e 1 \|c 11 \|h 22-22

Indexfelder

matchkey_str	article:22306056:2006----::hpeomnsaktnatoiainfigi
hierarchy_sort_str	2006
publishDate	2006
allfields	10.2165/00128413-200615620-00062 doi (DE-627)SPR035267208 (SPR)00128413-200615620-00062-e DE-627 ger DE-627 rakwb eng CHMP recommends marketing authorisation of pioglitazone/glimepiride 2006 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2006 Diabetes Mellitus (dpeaa)DE-He213 Marketing (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1562(2006), 1 vom: Nov., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1562 year:2006 number:1 month:11 pages:22-22 https://dx.doi.org/10.2165/00128413-200615620-00062 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1562 2006 1 11 22-22
spelling	10.2165/00128413-200615620-00062 doi (DE-627)SPR035267208 (SPR)00128413-200615620-00062-e DE-627 ger DE-627 rakwb eng CHMP recommends marketing authorisation of pioglitazone/glimepiride 2006 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2006 Diabetes Mellitus (dpeaa)DE-He213 Marketing (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1562(2006), 1 vom: Nov., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1562 year:2006 number:1 month:11 pages:22-22 https://dx.doi.org/10.2165/00128413-200615620-00062 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1562 2006 1 11 22-22
allfields_unstemmed	10.2165/00128413-200615620-00062 doi (DE-627)SPR035267208 (SPR)00128413-200615620-00062-e DE-627 ger DE-627 rakwb eng CHMP recommends marketing authorisation of pioglitazone/glimepiride 2006 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2006 Diabetes Mellitus (dpeaa)DE-He213 Marketing (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1562(2006), 1 vom: Nov., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1562 year:2006 number:1 month:11 pages:22-22 https://dx.doi.org/10.2165/00128413-200615620-00062 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1562 2006 1 11 22-22
allfieldsGer	10.2165/00128413-200615620-00062 doi (DE-627)SPR035267208 (SPR)00128413-200615620-00062-e DE-627 ger DE-627 rakwb eng CHMP recommends marketing authorisation of pioglitazone/glimepiride 2006 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2006 Diabetes Mellitus (dpeaa)DE-He213 Marketing (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1562(2006), 1 vom: Nov., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1562 year:2006 number:1 month:11 pages:22-22 https://dx.doi.org/10.2165/00128413-200615620-00062 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1562 2006 1 11 22-22
allfieldsSound	10.2165/00128413-200615620-00062 doi (DE-627)SPR035267208 (SPR)00128413-200615620-00062-e DE-627 ger DE-627 rakwb eng CHMP recommends marketing authorisation of pioglitazone/glimepiride 2006 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2006 Diabetes Mellitus (dpeaa)DE-He213 Marketing (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1562(2006), 1 vom: Nov., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1562 year:2006 number:1 month:11 pages:22-22 https://dx.doi.org/10.2165/00128413-200615620-00062 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1562 2006 1 11 22-22
language	English
source	Enthalten in Inpharma weekly 1562(2006), 1 vom: Nov., Seite 22-22 volume:1562 year:2006 number:1 month:11 pages:22-22
sourceStr	Enthalten in Inpharma weekly 1562(2006), 1 vom: Nov., Seite 22-22 volume:1562 year:2006 number:1 month:11 pages:22-22
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Diabetes Mellitus Marketing Type Diabetes Mellitus Metformin Type Diabetes
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2006-11-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035267208
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035267208</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519084836.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2006 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200615620-00062</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035267208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200615620-00062-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">CHMP recommends marketing authorisation of pioglitazone/glimepiride</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2006</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2006</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metformin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1562(2006), 1 vom: Nov., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1562</subfield><subfield code="g">year:2006</subfield><subfield code="g">number:1</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200615620-00062</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1562</subfield><subfield code="j">2006</subfield><subfield code="e">1</subfield><subfield code="c">11</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	CHMP recommends marketing authorisation of pioglitazone/glimepiride Diabetes Mellitus (dpeaa)DE-He213 Marketing (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213
topic	misc Diabetes Mellitus misc Marketing misc Type Diabetes Mellitus misc Metformin misc Type Diabetes
spellingShingle	misc Diabetes Mellitus misc Marketing misc Type Diabetes Mellitus misc Metformin misc Type Diabetes CHMP recommends marketing authorisation of pioglitazone/glimepiride
topic_unstemmed	misc Diabetes Mellitus misc Marketing misc Type Diabetes Mellitus misc Metformin misc Type Diabetes
topic_browse	misc Diabetes Mellitus misc Marketing misc Type Diabetes Mellitus misc Metformin misc Type Diabetes
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	CHMP recommends marketing authorisation of pioglitazone/glimepiride
ctrlnum	(DE-627)SPR035267208 (SPR)00128413-200615620-00062-e
title_full	CHMP recommends marketing authorisation of pioglitazone/glimepiride
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2006
contenttype_str_mv	txt
container_start_page	22
container_volume	1562
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200615620-00062
title_sort	chmp recommends marketing authorisation of pioglitazone/glimepiride
title_auth	CHMP recommends marketing authorisation of pioglitazone/glimepiride
abstract	© Adis International Ltd 2006
abstractGer	© Adis International Ltd 2006
abstract_unstemmed	© Adis International Ltd 2006
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	CHMP recommends marketing authorisation of pioglitazone/glimepiride
url	https://dx.doi.org/10.2165/00128413-200615620-00062
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200615620-00062
up_date	2024-07-03T14:00:54.506Z
_version_	1803566715513077760
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035267208</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519084836.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2006 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200615620-00062</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035267208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200615620-00062-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">CHMP recommends marketing authorisation of pioglitazone/glimepiride</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2006</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2006</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metformin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1562(2006), 1 vom: Nov., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1562</subfield><subfield code="g">year:2006</subfield><subfield code="g">number:1</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200615620-00062</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1562</subfield><subfield code="j">2006</subfield><subfield code="e">1</subfield><subfield code="c">11</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
score	7.399124

Nicht das Richtige dabei?

Schreiben Sie uns!

CHMP recommends marketing authorisation of pioglitazone/glimepiride

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?